Literature DB >> 11345363

New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study.

F Ledru1, P Ducimetière, S Battaglia, D Courbon, F Beverelli, L Guize, J L Guermonprez, B Diébold.   

Abstract

OBJECTIVES: The goal of this research was to study coronary atherosclerosis in patients with type 2 diabetes compared with patients without diabetes according to the new definition of diabetes advocated by the American Diabetes Association in 1997.
BACKGROUND: Patients with diabetes (fasting plasma glucose above 7.0 mM/L) have a higher risk of cardiovascular death. The correlation with the pattern and severity of their coronary atherosclerosis, especially in the new patients with "mild" diabetes (7.0 mM/L < or = fasting plasma glucose < 7.8 mM/L), remains unclear.
METHODS: A cohort of 466 patients undergoing coronary angiography but free of any previous infarction, coronary intervention and insulin therapy were prospectively recruited. Ninety-three had diabetes (fasting plasma glucose > 7.0 mM/L or hypoglycemic oral treatment). Five angiographic indexes were calculated to describe severity and extent of coronary atherosclerosis.
RESULTS: Overall, patients with diabetes had more diffuse coronary atherosclerosis, a greater prevalence of mild, moderate and severe stenoses and a two-fold higher occlusion rate than patients without diabetes, even after adjustment for age, gender, body mass index, hypertension, lipid parameters, smoking, family history of cardiovascular events and ischemic symptoms. Patients with "mild diabetes" had a coronary atherosclerosis pattern more similar to patients with normal fasting plasma glucose than to patients formerly defined as diabetic according to the World Health Organization criteria, except that they had a higher prevalence of <50% stenoses.
CONCLUSIONS: In patients with type 2 diabetes, those with 7.0 mM/L < or = fasting plasma glucose < 7.7 mM/L have a slightly greater prevalence of mildly severe lesions that may partly explain their higher cardiovascular event rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345363     DOI: 10.1016/s0735-1097(01)01183-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study.

Authors:  Z Kadri; N Danchin; L Vaur; Y Cottin; P Guéret; M Zeller; J-M Lablanche; D Blanchard; G Hanania; N Genès; J-P Cambou
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

Review 2.  [Revascularization of coronary artery disease in diabetes mellitus].

Authors:  Paul Wexberg; Franz Weidinger
Journal:  Wien Med Wochenschr       Date:  2010-01

Review 3.  Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients with Diabetes Mellitus: a Treatment-Risk Paradox.

Authors:  Juan F Iglesias; Sophie Degrauwe; Fabio Rigamonti; Stéphane Noble; Marco Roffi
Journal:  Curr Cardiol Rep       Date:  2019-02-21       Impact factor: 2.931

4.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

Review 5.  Cardiovascular disease in diabetes: where does glucose fit in?

Authors:  Jane E B Reusch; Cecilia C Low Wang
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

6.  Coronary artery plaque characterization using MDCT in symptomatic and asymptomatic subgroups of diabetic and non-diabetic population-a comparative retrospective study.

Authors:  Preeti Gupta; Naveen Kumar Agarwal; Atul Kapoor
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-01-15

7.  Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?

Authors:  Jane E B Reusch
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision.

Authors:  Antonio Sergio Rocha; Paulo Dutra; Andrea De Lorenzo
Journal:  Curr Cardiol Rev       Date:  2010-11

9.  Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Xi-Ying Liang; Yan Li; Xuan Qiao; Wen-Jiao Zhang; Zhi-Lu Wang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

10.  Impact of diabetes on long term follow-up of elderly patients with chronic total occlusion post percutaneous coronary intervention.

Authors:  Wei Liu; Kenji Wagatsuma; Hideo Nii; Mikihito Toda; Hideo Amano; Yasuto Uchida
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.